生殖医学杂志

参考文献

[1] Rönö K,Rissanen E,Bergh C,et al.The neurodevelopmental morbidity of children born after assisted reproductive technology:a Nordic register study from the Committee of Nordic Assisted Reproductive Technology and Safety group[J].Fertil Steril,2022,117:1026-1037.

[2] Magnus MC,Skåra KH,Carlsen E∅,et al.Use of assisted reproductive technologies for male and female infertility and perinatal outcomes[J].Fertil Steril,2025,124:270-280.

[3] Liao YJ,Fang NW,Yao CS,et al.Neonatal outcomes in infants conceived using assisted reproductive technologies:A single medical center cohort study[J].Pediatr Neonatol,2024,65:469-475.

[4] Münch ML,Lia M,Wolf B,et al.Multidisciplinary assessment of the impact of assisted reproductive techniques on pregnancy and long-term outcomes of mother and child:Foundation of the LE-REP (Leipzig Reproductive Health) Center[J].J Reprod Immunol,2025,169:104457.

[5] Pinborg A,Wennerholm UB,Bergh C.Long-term outcomes for children conceived by assisted reproductive technology[J].Fertil Steril,2023,120:449-456.

[6] Zhang S,Luo Q,Meng R,et al.Long-term health risk of offspring born from assisted reproductive technologies[J].J Assist Reprod Genet,2024,41:527-550.

[7] Chih HJ,Elias F,Gaudet L,et al.Assisted reproductive technology and hypertensive disorders of pregnancy:systematic review and meta-analyses[J].BMC Pregnancy Childbirth,2021,21:449.

[8] H Petersen S,Westvik-Johari K,Spangmose AL,et al.Risk of hypertensive disorders in pregnancy after fresh and frozen embryo transfer in assisted reproduction:a population-based cohort study with within-sibship analysis[J].Hypertension,2023,80:e6-e16.

[9] Fan L,Li N,Liu X,et al.Hormone replacement treatment regimen is associated with a higher risk of hypertensive disorders of pregnancy in women undergoing frozen-thawed embryo transfer[J].Front Endocrinol (Lausanne),2023,14:1133978.

[10] Bonagura TW,Pepe GJ,Enders AC,et al.Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy[J].Endocrinology,2008,149:5078-5087.

[11] Chen ZJ,Shi Y,Sun Y,et al.Fresh versus frozen embryos for infertility in the polycystic ovary syndrome[J].N Engl J Med,2016,375:523-533.

[12] 胡耀晖，姚田，马钊.冻融胚胎移植周期内膜准备方案与妊娠期高血压疾病相关性研究[J].生殖医学杂志，2023,32:1662-1667.

[13] Sacks DB,Arnold M,Bakris GL,et al.Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J].Diabetes Care,2023,46:e151-e199.

[14] Bianchi C,Brocchi A,Baronti W,et al.Assisted reproductive technology,risk of gestational diabetes,and perinatal outcomes in singleton pregnancies[J].Diabetes Metab Res Rev,2023,39:e3625.

[15] Li M,Chen Y,Wang Y,et al.Maternal gestational diabetes in singleton pregnancies conceived by ART may be modified by periconceptional B vitamins[J].Front Nutr,2022,9:1069911.

[16] Xiong Y,Wang J,Qi Y,et al.Dose-response association between maternal pre-pregnancy bodyweight and gestational diabetes mellitus following ART treatment:a population-based cohort study[J].Reprod Biol Endocrinol,2022,20:92.

[17] Kouhkan A,Khamseh ME,Pirjani R,et al.Obstetric and perinatal outcomes of singleton pregnancies conceived via assisted reproductive technology complicated by gestational diabetes mellitus:a prospective cohort study[J].BMC Pregnancy Childbirth,2018,18:495.

[18] Perros P,Koutras A,Prokopakis I,et al.Comparing perinatal outcomes of assisted reproductive technology (ART)-induced vs.naturally conceived twin pregnancies[J].Cureus,2024,16:e69842.

[19] Johnston J,Gusmano MK,Patrizio P.Preterm births,multiples,and fertility treatment:recommendations for changes to policy and clinical practices[J].Fertil Steril,2014,102:36-39.

[20] Qin J,Wang H,Sheng X,et al.Pregnancy-related complications and adverse pregnancy outcomes in multiple pregnancies resulting from assisted reproductive technology:a meta-analysis of cohort studies[J].Fertil Steril,2015,103:1492-1508.

[21] Chen L,Dong Q,Weng R.Maternal and neonatal outcomes of dichorionic twin pregnancies achieved with assisted reproductive technology:meta-analysis of contemporary data[J].J Assist Reprod Genet,2024,41:581-589.

[22] Monk D.Genomic imprinting in the human placenta[J].Am J Obstet Gynecol,2015,213:S152-S162.

[23] Landsverk E,Westvik-Johari K,Wennerholm UB,et al.Risk of placenta previa in assisted reproductive technology:A Nordic population study with sibling analyses[J].PLoS Med,2025,22:e1004536.

[24] Kong F,Fu Y,Shi H,et al.Placental abnormalities and placenta-related complications following in-vitro fertilization:based on national hospitalized data in China[J].Front Endocrinol (Lausanne),2022,13:924070.

[25] Chen S,Wang J,Wang M,et al.In vitro fertilization alters phospholipid profiles in mouse placenta[J].J Assist Reprod Genet,2019,36:557-567.

[26] Sui L,An L,Tan K,et al.Dynamic proteomic profiles of in vivo- and in vitro-produced mouse postimplantation extraembryonic tissues and placentas[J].Biol Reprod,2014,91:155.

[27] Rossen LM,Ahrens KA,Branum AM.Trends in risk of pregnancy loss among us women,1990-2011[J].Paediatr Perinat Epidemiol,2018,32:19-29.

[28] Shuai J,Chen QL,Chen WH,et al.Early spontaneous abortion in fresh- and frozen-embryo transfers:an analysis of over 35,000 transfer cycles[J].Front Endocrinol (Lausanne),2022,13:875798.

[29] Qu P,Yan M,Zhao D,et al.Association between pre-pregnancy body mass index and miscarriage in an assisted reproductive technology population:a 10-year cohort study[J].Front Endocrinol (Lausanne),2021,12:646162.

[30] Boychuk AV,Kotsabyn NV,Yakymchuk JB,et al.Pregravid preparation of women with chronic endometritis in IVF cycles[J].Wiad Lek,2024,77:25-28.

[31] Wang R,Shi Q,Jia B,et al.Association of preterm singleton birth with fertility treatment in the US[J].JAMA Netw Open,2022,5:e2147782.

[32] Zhao J,Xu B,Zhang Q,et al.Which one has a better obstetric and perinatal outcome in singleton pregnancy,IVF/ICSI or FET?:a systematic review and meta-analysis[J].Reprod Biol Endocrinol,2016,14:51.

[33] Zaat TR,Kostova EB,Korsen P,et al.Obstetric and neonatal outcomes after natural versus artificial cycle frozen embryo transfer and the role of luteal phase support:a systematic review and meta-analysis[J].Hum Reprod Update,2023,29:634-654.

[34] Singh N,Malhotra N,Mahey R,et al.In vitro fertilization as an independent risk factor for perinatal complications:Single-center 10 years cohort study[J].JBRA Assist Reprod,2023,27:197-203.

[35] Xiong Y,Zang X,Xie T,et al.Additional adverse perinatal outcomes with no effect on neonatal mortality and birth defects in pregnancies conceived by assisted reproductive technology[J].Front Pediatr,2022,10:809259.

[36] Pelikh A,Smith KR,Myrskylä M,et al.Medically assisted reproduction treatment types and birth outcomes:a between-family and within-family analysis[J].Obstet Gynecol,2022,139:211-222.

[37] Zhang L,Zhang W,Xu H,et al.Birth defects surveillance after assisted reproductive technology in Beijing:a whole of population-based cohort study[J].BMJ Open,2021,11:e044385.

[38] Sargisian N,Petzold M,Furenäs E,et al.Congenital heart defects in children born after assisted reproductive technology:a CoNARTaS study[J].Eur Heart J,2024,45:4840-4858.

[39] Lu Y,Liu L,Zhang P,et al.Risk of birth defects in children conceived with assisted reproductive technology:A meta-analysis[J].Medicine (Baltimore),2022,101:e32405.

[40] Snir A,Wainstock T,Gutvirtz G,et al.Long-term gastrointestinal morbidity among twins conceived by assisted reproductive technology[J].Eur J Obstet Gynecol Reprod Biol,2025,311:114030.

[41] Badger T,Johns E,Wilson T,et al.Developmental outcomes of very preterm infants conceived through in vitro fertilization[J].Arch Med Res,2024,55:103136.

[42] Loukopoulos T,Zikopoulos A,Kolibianakis E,et al.High-risk outcomes in in vitro fertilization pregnancies for women of a very advanced maternal age:insights from a multi-hospital study in Greece[J].J Clin Med,2025,14:1323.

[43] Zhang R,Wang X,Mo M,et al.Insulin resistance as a determinant of fertilization efficiency in polycystic ovary syndrome patients undergoing IVF/ICSI:a retrospective cohort study[J].Reprod Biol Endocrinol,2025,23:120.

[44] Zhou F,Zhao F,Jin X,et al.Factors affecting clinical outcomes after IVF-ET for infertile young patients with ovarian endometrioma:a 5-year retrospective cohort study[J].Medicine (Baltimore),2022,101:e29793.

[45] Harvey AJ,Willson BE,Surrey ES,et al.Ovarian stimulation protocols:impact on oocyte and endometrial quality and function[J].Fertil Steril,2025,123:10-21.

[46] Wei D,Liu JY,Sun Y,et al.Frozen versus fresh single blastocyst transfer in ovulatory women:a multicentre,randomised controlled trial[J].Lancet,2019,393:1310-1318.

[47] 孙贻娟，黄国宁，孙海翔，等.关于胚胎移植数目的中国专家共识[J].生殖医学杂志，2018,27:940-945.

[48] ESHRE Guideline Group on the Number of Embryos to Transfer,Alteri A,Arroyo G,et al.ESHRE guideline:number of embryos to transfer during IVF/ICSI†[J].Hum Reprod,2024,39:647-657.